HL403 is a potent dual inhibitor targeting BRD4 and Src, with an IC50 value of 133 nM for BRD4 inhibition and 4.5 nM for Src inhibition. HL403 demonstrates anticancer activity.
Formula:
C44H46Cl2N12O4S2
Target:
Epigenetic Reader Domain,Src
* VAT and and shipping costs not included. Errors and price changes excepted
